XRN

SEC source: 0001144204-19-029243 · tv522730_form4.xml · derivative · entry 1

MOORE ROSCOE M JR · CIK 0001459411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,185

Underlying: Common Stock · 3,705 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 29, 2020, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-029246 · tv522732_form4.xml · derivative · entry 1

Wittman Lori · CIK 0001615562 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,185

Underlying: Common Stock · 3,705 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 29, 2020, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-029245 · tv522731_form4.xml · derivative · entry 1

Marston Ronald · CIK 0001652392 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,130

Underlying: Common Stock · 3,705 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 29, 2020, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-029240 · tv522728_form4.xml · derivative · entry 1

Crowley Paula · CIK 0001743595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,185

Underlying: Common Stock · 3,821 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 29, 2020, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-029239 · tv522727_form4.xml · derivative · entry 1

Cole Henry · CIK 0001652393 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,130

Underlying: Common Stock · 3,705 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 29, 2020, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-014858 · tv516521_form4.xml · nonDerivative · entry 2

MOORE ROSCOE M JR · CIK 0001459411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001144204-19-014858 · tv516521_form4.xml · nonDerivative · entry 1

MOORE ROSCOE M JR · CIK 0001459411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,945

SEC source: 0001144204-19-012799 · tv515756_form4.xml · derivative · entry 3

Webb Allen · CIK 0001676513 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,252

Underlying: Common Stock · 2,470 shares

Expires not disclosed

F5 · security: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F5 · date: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F5 · shares: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012799 · tv515756_form4.xml · derivative · entry 2

Webb Allen · CIK 0001676513 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,782

Underlying: Common Stock · 5,164 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012799 · tv515756_form4.xml · derivative · entry 1

Webb Allen · CIK 0001676513 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,618

Underlying: Common Stock · 9,031 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2019 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2018 and 50% of the LTIP Units will vest on March 5, 2020, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012800 · tv515757_form4.xml · derivative · entry 3

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,334

Underlying: Common Stock · 4,500 shares

Expires not disclosed

F5 · security: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F5 · date: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F5 · shares: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012800 · tv515757_form4.xml · derivative · entry 2

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,834

Underlying: Common Stock · 9,136 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012800 · tv515757_form4.xml · derivative · entry 1

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,698

Underlying: Common Stock · 18,382 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2019 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2018 and 50% of the LTIP Units will vest on March 5, 2020, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012796 · tv515754_form4.xml · derivative · entry 3

KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,276

Underlying: Common Stock · 3,250 shares

Expires not disclosed

F5 · security: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F5 · date: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F5 · shares: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012796 · tv515754_form4.xml · derivative · entry 2

KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,026

Underlying: Common Stock · 6,356 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012796 · tv515754_form4.xml · derivative · entry 1

KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,670

Underlying: Common Stock · 13,275 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2019 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2018 and 50% of the LTIP Units will vest on March 5, 2020, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012798 · tv515755_form4.xml · derivative · entry 3

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,129

Underlying: Common Stock · 2,100 shares

Expires not disclosed

F5 · security: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F5 · date: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F5 · shares: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012798 · tv515755_form4.xml · derivative · entry 2

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,029

Underlying: Common Stock · 4,370 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012798 · tv515755_form4.xml · derivative · entry 1

Holley Danica · CIK 0001657320 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,659

Underlying: Common Stock · 8,578 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2019 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2018 and 50% of the LTIP Units will vest on March 5, 2020, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012794 · tv515753_form4.xml · derivative · entry 3

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,328

Underlying: Common Stock · 3,125 shares

Expires not disclosed

F5 · security: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F5 · date: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F5 · shares: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012794 · tv515753_form4.xml · derivative · entry 2

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,203

Underlying: Common Stock · 8,342 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012794 · tv515753_form4.xml · derivative · entry 1

Leon Alfonzo · CIK 0001647511 · Chief Investment Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,861

Underlying: Common Stock · 12,765 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2019 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2018 and 50% of the LTIP Units will vest on March 5, 2020, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012791 · tv515752_form4.xml · derivative · entry 3

Barber Jamie Allen · CIK 0001705686 · Secretary and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,007

Underlying: Common Stock · 2,750 shares

Expires not disclosed

F5 · security: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F5 · date: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F5 · shares: 50% of the LTIP Units vested at issuance and the remaining will vest on March 5, 2020 pursuant to the grant award agreement stipulations.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012791 · tv515752_form4.xml · derivative · entry 2

Barber Jamie Allen · CIK 0001705686 · Secretary and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,257

Underlying: Common Stock · 5,561 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2020, 2021 and 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-012791 · tv515752_form4.xml · derivative · entry 1

Barber Jamie Allen · CIK 0001705686 · Secretary and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,696

Underlying: Common Stock · 8,876 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2019 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2018 and 50% of the LTIP Units will vest on March 5, 2020, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on April 12, 2018.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after the first anniversary of the grant date (so long as capital parity has been achieved) for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-19-004522 · tv512296_4.xml · derivative · entry 2

MOORE ROSCOE M JR · CIK 0001459411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,480

Underlying: Common Stock · 5,945 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F1 · derivative.exercise_price: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.exercise_date: On May 18, 2017, the reporting person was granted 5,945 LTIP Units, which vested on May 18, 2018.

F1 · derivative.expiration_date: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: On May 18, 2017, the reporting person was granted 5,945 LTIP Units, which vested on May 18, 2018.

SEC source: 0001144204-19-004522 · tv512296_4.xml · nonDerivative · entry 1

MOORE ROSCOE M JR · CIK 0001459411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,945

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001651377-18-000002 · primary_doc.xml · nonDerivative · entry 1

Zhang Huiqi · CIK 0001671732 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Through The Superior Glory Enterprises Trust

Disclosed balance after: 3,715,611

F1 · price: On December 27, 2018, the shares reported herein were transferred from Zensun Group Limited to Notable Reward Limited, a British Virgin Islands limited company, which is wholly owned and controlled by Superior Glory Enterprises Limited, a British Virgin Islands limited company, which in turn is wholly owned by The Superior Glory Enterprises Trust, a revocable Singapore reserved power trust. Zhang Huiqi is a beneficiary of The Superior Glory Enterprises Trust.

SEC source: 0001651377-18-000001 · primary_doc.xml · nonDerivative · entry 1

Huang Yanping · CIK 0001651377 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Through The Superior Glory Enterprises Trust

Disclosed balance after: 3,715,611

F1 · shares: On December 27, 2018, Huang Yanping transferred her wholly owned interest in Zensun Group Limited (the previous holder of the shares reported herein) to Notable Reward Limited, a British Virgin Islands limited company, which is owned and controlled by Huang Yanping. Notable Rewards Limited is wholly owned by Superior Glory Enterprises Limited, a British Virgin Islands limited company, which in turn is wholly owned by The Superior Glory Enterprises Trust, a revocable Singapore reserve power trust. Huang Yanping is the sole director of Notable Reward Limited,as well as the settlor, protector, and beneficiary of The Superior Glory Enterprises Trust.

F1 · price: On December 27, 2018, Huang Yanping transferred her wholly owned interest in Zensun Group Limited (the previous holder of the shares reported herein) to Notable Reward Limited, a British Virgin Islands limited company, which is owned and controlled by Huang Yanping. Notable Rewards Limited is wholly owned by Superior Glory Enterprises Limited, a British Virgin Islands limited company, which in turn is wholly owned by The Superior Glory Enterprises Trust, a revocable Singapore reserve power trust. Huang Yanping is the sole director of Notable Reward Limited,as well as the settlor, protector, and beneficiary of The Superior Glory Enterprises Trust.

SEC source: 0001669358-18-000001 · primary_doc.xml · nonDerivative · entry 1

ZH USA, LLC · CIK 0001669358 · 10% owner

ZH International Holdings, Ltd. · CIK 0001268576 · 10% owner

Joy Town Inc. · CIK 0001651644 · 10% owner

Zensun Group Ltd · CIK 0001755835 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,715,611

F1 · ownership.direct: ZH USA, LLC is the direct holder of these securities and is a beneficial owner of more than five percent of the outstanding shares of the Issuer's common stock. The other reporting persons are indirect owners, through ZH USA, LLC, of more than five percent of the outstanding shares of the Issuer's common stock.

SEC source: 0001144204-18-065133 · tv509198_form4.xml · nonDerivative · entry 1

Zhang Jing Guo · CIK 0001651567 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Directly owned by ZH USA, LLC

Disclosed balance after: 3,715,611

F1 · ownership.nature: Zhang Jing Guo currently serves as President of ZH USA, LLC, which is a beneficial owner of more than five percent of the outstanding shares of the Issuer's common stock. ZH USA, LLC is the direct holder of these securities.

SEC source: 0001669358-18-000002 · primary_doc.xml · nonDerivative · entry 1

Huang Yanping · CIK 0001651377 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Through ZH USA, LLC

Disclosed balance after: 3,715,611

F1 · ownership.nature: ZH USA, LLC is the direct holder of these securities and is a beneficial owner of more than five percent of the outstanding shares of the Issuer's common stock. The reporting person is an indirect owner of ZH USA, LLC.

SEC source: 0001144204-18-059472 · tv507217_4.xml · nonDerivative · entry 1

Cole Henry · CIK 0001652393 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,120

SEC source: 0001144204-18-058834 · tv506905_4.xml · nonDerivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was an inadvertent broker-initiated sale of shares from an account maintained by the Reporting Person. Such sale is matchable under Section 16(b) of the Securities Exchange Act of 1934 against a portion of the reporting person's purchase of 475 shares of the Company's common stock on May 11, 2018, at a price of $8.41 per share. The reporting person has agreed to pay the Company $289.75, representing the full amount of profit realized in connection with the inadvertent sale.

SEC source: 0001755835-18-000002 · primary_doc.xml · nonDerivative · entry 2

Huang Yanping · CIK 0001651377 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Through Zensun Group Limited

Disclosed balance after: 2,604,500

F1 · kind: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

F1 · shares: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

F1 · price: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

F1 · ownership.nature: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

SEC source: 0001755835-18-000002 · primary_doc.xml · nonDerivative · entry 1

Huang Yanping · CIK 0001651377 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Through Joy Town, Inc.

Disclosed balance after: 2,604,500

F1 · kind: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

F1 · shares: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

F1 · price: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

F1 · ownership.nature: On August 17, 2018, Huang Yanping, the 100% owner of Joy Town, Inc. in simultaneous transactions agreed to surrender the sole share issued by Joy Town, Inc. and caused Zensun Group Limited to apply for one share of Joy Town, Inc. Joy Town, Inc. and Zensun Group Limited are both wholly owned by Huang Yanping. These transactions gave Zensun Group Limited direct control over Joy Town, Inc. and indirect control over ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer.

SEC source: 0001651567-18-000001 · primary_doc.xml · nonDerivative · entry 1

Zhang Jing Guo · CIK 0001651567 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,604,500

F1 · shares: On August 17, 2018, Zensun Group Limited applied and received the sole share of Joy Town, Inc. As a result of this transaction, Zensun Group Limited became a direct owner of Joy Town, Inc. and through Joy Town, Inc., Zensun Group Limited is an indirect owner of ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer. The Reporting Person, Zhang Jing Guo, is a director of Zensun Group Limited. Mr. Zhang is currently a director of the Issuer and is reporting in this Form 4 his appointment as director of Zensun Group Limited, an indirect owner of the Issuer.

F1 · price: On August 17, 2018, Zensun Group Limited applied and received the sole share of Joy Town, Inc. As a result of this transaction, Zensun Group Limited became a direct owner of Joy Town, Inc. and through Joy Town, Inc., Zensun Group Limited is an indirect owner of ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer. The Reporting Person, Zhang Jing Guo, is a director of Zensun Group Limited. Mr. Zhang is currently a director of the Issuer and is reporting in this Form 4 his appointment as director of Zensun Group Limited, an indirect owner of the Issuer.

F1 · ownership.nature: On August 17, 2018, Zensun Group Limited applied and received the sole share of Joy Town, Inc. As a result of this transaction, Zensun Group Limited became a direct owner of Joy Town, Inc. and through Joy Town, Inc., Zensun Group Limited is an indirect owner of ZH International Holdings, Ltd., ZH USA, LLC, and the Issuer. The Reporting Person, Zhang Jing Guo, is a director of Zensun Group Limited. Mr. Zhang is currently a director of the Issuer and is reporting in this Form 4 his appointment as director of Zensun Group Limited, an indirect owner of the Issuer.

SEC source: 0001144204-18-034430 · tv496571_form4.xml · derivative · entry 1

Crowley Paula · CIK 0001743595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,364

Underlying: Common Stock · 3,364 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on June 14, 2019, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F1 · ownership.direct: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

SEC source: 0001144204-18-033744 · tv496309_form4.xml · nonDerivative · entry 1

Marston Ronald · CIK 0001652392 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,830

SEC source: 0001144204-18-031996 · tv495394_form4.xml · derivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,425

Underlying: Common Stock · 3,480 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 30, 2019, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-18-031997 · tv495397_form4.xml · derivative · entry 1

MOORE ROSCOE M JR · CIK 0001459411 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,425

Underlying: Common Stock · 3,480 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 30, 2019, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-18-032003 · tv495403_form4.xml · derivative · entry 1

Wittman Lori · CIK 0001615562 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,480

Underlying: Common Stock · 3,480 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 30, 2019, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-18-032001 · tv495402_form4.xml · derivative · entry 1

Marston Ronald · CIK 0001652392 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,425

Underlying: Common Stock · 3,480 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 30, 2019, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-18-031999 · tv495399_form4.xml · derivative · entry 1

Cole Henry · CIK 0001652393 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,425

Underlying: Common Stock · 3,480 shares

Expires not disclosed

F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · shares: LTIP Units vest on May 30, 2019, subject to the Reporting Person's continued service as a director until such date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-18-027642 · tv493886_form4.xml · nonDerivative · entry 1

Cypher Matthew · CIK 0001670718 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,675

SEC source: 0001144204-18-014405 · tv488435_form4.xml · nonDerivative · entry 3

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,740

SEC source: 0001144204-18-014405 · tv488435_form4.xml · nonDerivative · entry 2

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,740

SEC source: 0001144204-18-014405 · tv488435_form4.xml · nonDerivative · entry 1

Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,740

SEC source: 0001144204-18-013437 · tv488026_form4.xml · derivative · entry 2

Webb Allen · CIK 0001676513 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,587

Underlying: Common Stock · 7,196 shares

Expires not disclosed

F4 · security: LTIP Units vest in equal one-third installments on March 5 of 2019, 2020 and 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F4 · date: LTIP Units vest in equal one-third installments on March 5 of 2019, 2020 and 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F4 · shares: LTIP Units vest in equal one-third installments on March 5 of 2019, 2020 and 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

SEC source: 0001144204-18-013437 · tv488026_form4.xml · derivative · entry 1

Webb Allen · CIK 0001676513 · SVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,391

Underlying: Common Stock · 7,961 shares

Expires not disclosed

F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 5, 2018 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2017 and 50% of the LTIP Units will vest on December 31, 2018, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date.

F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F3 · date: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.1 to the Issuer's Current Report on Form 8-K filed on March 6, 2017.

F3 · shares: Awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.1 to the Issuer's Current Report on Form 8-K filed on March 6, 2017.

F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.